- Home
- AXS vs CORT Comparison
AXS vs CORT Comparison
Compare AXS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXS
- CORT
- Stock Information
- Founded
- AXS 2001
- CORT 1998
- Country
- AXS Bermuda
- CORT United States
- Employees
- AXS N/A
- CORT N/A
- Industry
- AXS Property-Casualty Insurers
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- AXS Finance
- CORT Health Care
- Exchange
- AXS Nasdaq
- CORT Nasdaq
- Market Cap
- AXS 8.1B
- CORT 7.1B
- IPO Year
- AXS N/A
- CORT N/A
- Fundamental
- Price
- AXS $102.54
- CORT $75.08
- Analyst Decision
- AXS Strong Buy
- CORT Strong Buy
- Analyst Count
- AXS 9
- CORT 4
- Target Price
- AXS $107.75
- CORT $142.00
- AVG Volume (30 Days)
- AXS 565.6K
- CORT 1.3M
- Earning Date
- AXS 04-30-2025
- CORT 05-05-2025
- Dividend Yield
- AXS 1.72%
- CORT N/A
- EPS Growth
- AXS 54.31
- CORT 8.36
- EPS
- AXS 10.08
- CORT 1.14
- Revenue
- AXS $6,055,200,000.00
- CORT $685,446,000.00
- Revenue This Year
- AXS $4.15
- CORT $35.85
- Revenue Next Year
- AXS $5.74
- CORT $35.22
- P/E Ratio
- AXS $10.14
- CORT $65.80
- Revenue Growth
- AXS 5.79
- CORT 30.93
- 52 Week Low
- AXS $68.02
- CORT $25.35
- 52 Week High
- AXS $101.42
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- AXS 64.39
- CORT 57.68
- Support Level
- AXS $98.40
- CORT $68.86
- Resistance Level
- AXS $102.36
- CORT $73.36
- Average True Range (ATR)
- AXS 2.23
- CORT 3.26
- MACD
- AXS 0.26
- CORT 0.12
- Stochastic Oscillator
- AXS 99.79
- CORT 95.28
About AXS Axis Capital Holdings Limited
Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.